• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

FDA Clearance

RapidAI Receives FDA Clearance for Rapid SDH (Subdural Hematoma) for Trauma Care

by Fred Pennic 11/10/2023 Leave a Comment

RapidAI Receives FDA Clearance for Rapid SDH (Subdural Hematoma) for Trauma Care

What You Should Know: - RapidAI has received FDA clearance for Rapid SDH, its AI-powered module for the detection and notification of suspected hemispheric acute and chronic subdural hematoma. - The need for the RapidAI solution is urgent, with SDH cases in US patients expected to increase by nearly 80% before 2040. AI Module for Detection of Hemispheric Subdural Hematomas Rapid SDH leverages AI to help neurocritical care teams identify suspected hemispheric subdural hemorrhage
Read More

Empatica Awarded New FDA Clearance for Cardiac Digital Biomarkers

by Fred Pennic 11/06/2023 Leave a Comment

Empatica Awarded New FDA Clearance for Cardiac Digital Biomarkers

What You Should Know: - Empatica, a digital health and AI company, has obtained FDA 510(k) clearance for two new digital biomarkers, pulse rate, and respiratory rate, on its Empatica Health Monitoring Platform. - This clearance expands the platform to include a total of six FDA-cleared digital biomarkers, out of the 128 digital measures supported, making it one of the most comprehensive solutions available for use in clinical trials. - The Empatica Health Monitoring Platform comprises a
Read More

Annalise.ai Receives FDA Clearance for Radiology Triage Device

by Syed Hamza Sohail 09/14/2023 Leave a Comment

Annalise.ai Receives FDA Clearance for Radiology Triage Device

What You Should Know: Annalise.ai, a leader in AI-powered medical imaging solutions, announced the receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the triage and notification of obstructive hydrocephalus (OHCP) on non-contrast brain CT scans.Annalise.ai has also received FDA Breakthrough Device Designation for its obstructive hydrocephalus software tool. This is the first radiology triage device to be granted Breakthrough status since the inception of the
Read More

What Role Can Consumer Health Technology Play in Diagnoses?

by David Smith, President at ilumivu 04/12/2023 Leave a Comment

What Role Can Consumer Health Technology Play in Diagnoses?

There’s an ongoing debate regarding the role that consumer health technology, like wearable health devices (i.e., smartwatches), can play in diagnostics, now and in the future. Because this is a relatively new technology, the scope of its potential impact is, at present, only scraping the surface. Even so, smartwatches and their connected health apps are reshaping the healthcare industry. This technology has the ability to not only make personalized healthcare more widely accessible, but its
Read More

AI-Enabled Butterfly Network Lung Tool Receives FDA Clearance

by Fred Pennic 04/03/2023 Leave a Comment

AI-Enabled Butterfly Network Lung Tool Receives FDA Clearance

What You Should Know: - Today, Butterfly Network announced it received 510(k) clearance from the FDA for a groundbreaking AI-enabled tool named AI-enabled Auto B-line Counter that will help physicians assess adults’ lungs and accelerate providers’ abilities to make informed treatment decisions. Butterfly used data inputs from hundreds of sites across the country to train and develop its AI algorithms, offering potential for a broad and diverse range of age, gender, body mass index, ethnicity,
Read More

TytoCare Receives FDA Clearance for AI-Powered Tyto Insights for Wheeze Detection

by Syed Hamza Sohail 03/15/2023 Leave a Comment

TytoCare and Overlake Partner to Expand Virtual Care Offerings

- TytoCare, a virtual care company enabling accessible, high-quality primary care from home, today announced that it received FDA clearance for its Tyto Insights for Wheeze Detection, paving the way for its rollout in the US. - The wheeze detection algorithm expands the company’s existing AI-powered Tyto Insights™ smart diagnostic capabilities, filling the quality gaps currently experienced with traditional telehealth and alleviating challenges imposed by the ongoing shortage of healthcare
Read More

Clarius Awarded FDA Clearance for AI Ultrasound Musculoskeletal Imaging App

by Syed Hamza Sohail 02/06/2023 Leave a Comment

Clarius Awarded FDA Clearance for AI Ultrasound Musculoskeletal Imaging App

What You Should Know: - Clarius Mobile Health, a leading provider of high-definition handheld ultrasound systems, receives 510(k) clearance for its new MSK AI model, which automatically identifies and measures tendons in the foot, ankle, and knee using artificial intelligence (AI). - The new MSK AI model will be available soon with the Clarius L7 HD3 and Clarius L15 HD3 high-frequency, wireless handheld ultrasound scanners. AI Driven Imaging To Improve
Read More

Selux Receives FDA Clearance for its Rapid Antibiotic Susceptibility Test (AST) System

by Jasmine Pennic 01/20/2023 Leave a Comment

Selux Receives FDA Clearance for its Rapid Antibiotic Susceptibility Test (AST) System

What You Should Know: - Selux Diagnostics has been granted 510(k) clearance from the US FDA for its Next Generation Phenotyping (NGP) System — a rapid antibiotic susceptibility (AST) testing platform able to determine a bacteria’s susceptibility to a specific panel of antimicrobial agents. - In vitro antimicrobial resistance test enables clinical labs to deliver targeted therapeutic results days faster than the current standard of care, clearing the path for personalized antibiotic
Read More

Valencell Unveils Calibration-Free, Cuffless Blood Pressure Monitor

by Syed Hamza Sohail 01/04/2023 Leave a Comment

Valencell to Unveil Calibration-Free, Cuffless Blood Pressure Monitor

What You Should Know: - Valencell, the company whose optical heart rate technology enabled the ability of wearables to accurately measure cardiovascular vitals during exercise, today announced plans to launch its own branded product line in the digital health sector as it concentrates efforts to bring solutions to market to manage chronic diseases. - The company’s first product candidate being showcased at CES is focused on helping people monitor and manage hypertension by combining
Read More

Dexcom Receives FDA Clearance for G7 Continuous Glucose Monitoring (CGM) System

by Jasmine Pennic 12/08/2022 Leave a Comment

Dexcom Receives FDA Clearance for G7 Continuous Glucose Monitoring (CGM) System 

What You Should Know: - The FDA has cleared Dexcom G7 continuous glucose monitoring (CGM) system in the U.S. for people with all types of diabetes ages two years and older, giving more people than ever access to a powerfully simple diabetes management solution. - Cleared as an integrated continuous glucose monitoring (iCGM) system, Dexcom G7 will be part of the most connected CGM ecosystem in the world, with real-time connectivity that can drive integrated insulin delivery systems, connect
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Go to page 6
  • Interim pages omitted …
  • Go to page 10
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |